DT, S., A, B., H, E., SA, K., M, L., T, K., . . . VL, S. (2021). Correction: Aberrant DNA Damage Response Pathways May Predict the Outcome of Platinum Chemotherapy in Ovarian Cancer. PloS one, 16(8), e0256051. https://doi.org/10.1371/journal.pone.0256051
Chicago Style (17th ed.) CitationDT, Stefanou, et al. "Correction: Aberrant DNA Damage Response Pathways May Predict the Outcome of Platinum Chemotherapy in Ovarian Cancer." PloS One 16, no. 8 (2021): e0256051. https://doi.org/10.1371/journal.pone.0256051.
MLA (9th ed.) CitationDT, Stefanou, et al. "Correction: Aberrant DNA Damage Response Pathways May Predict the Outcome of Platinum Chemotherapy in Ovarian Cancer." PloS One, vol. 16, no. 8, 2021, p. e0256051, https://doi.org/10.1371/journal.pone.0256051.